Literature DB >> 8166817

Is there a problem with long-term use of sumatriptan in migraine.

M J Osborne1, R C Austin, K J Dawson, L Lange.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8166817      PMCID： PMC2539187          DOI： 10.1136/bmj.308.6921.113a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

Review 1.  Rationale for the use of 5-HT1-like agonists in the treatment of migraine.

Authors:  W Feniuk; P P Humphrey; M J Perren; H E Connor; E T Whalley
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

2.  Treatment of acute migraine with subcutaneous sumatriptan.

Authors:  R K Cady; J K Wendt; J R Kirchner; J D Sargent; J F Rothrock; H Skaggs
Journal:  JAMA       Date:  1991-06-05       Impact factor: 56.272
  2 in total
  5 in total

1.  Sumatriptan and daily headache.

Authors:  T Catarci; G L Lenzi; R Cerbo; C Fieschi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-04       Impact factor: 10.154

2.  Analgesic headache.

Authors:  J Olesen
Journal:  BMJ       Date:  1995-02-25

3.  Long term use of sumatriptan.

Authors:  D K Lloyd; W S Arnold
Journal:  BMJ       Date:  1994-02-19

4.  Sumatriptan.

Authors:  H Kaube; A May; V Pfaffenrath
Journal:  BMJ       Date:  1994-06-11

5.  Drug dependence associated with triptans and ergot derivatives: a case/non-case study.

Authors:  Frédérique Beau-Salinas; Annie Pierre Jonville-Béra; Haware Cissoko; Lamiae Bensouda-Grimaldi; Elisabeth Autret-Leca
Journal:  Eur J Clin Pharmacol       Date:  2009-12-19       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.